The impact of key enzymes like Creatine kinase muscle-brain (CKMB), High-sensitivity C-reactive protein (HS-CRP + CRP), Creatine kinase muscle-brain (CKMB), concentration of cardiac troponin I (cTnL), myoglobin (Myo), cardiac biomarkers associated with numerous cardiovascular disease states8,9, and arylamine N-acetyltransferase (NAT), a phase II drug metabolizing enzyme were evaluated to ascertain toxicity and possible cardio protection10,11. The gene discussed is CRP; the disease is cardiovascular disorder.